Evotec Creates long-term Growth Opportunities by Initiating ‘Campus Levi-Montalcini’ in Verona
EVOTEC ACQUIRES THE VERONA SITE FROM GSK AND SECURES CAPACITY FOR LONG-TERM GROWTHEMPLOYEES VOTE FOR SITE TO BE NAMED "CAMPUS...
Staff
Klurfeld Cares Shines Light on Rare Medical Conditions Affecting Millions of Patients
Diana & Alex Klurfeld Launch ‘Klurfeld Cares' a New Awareness Website on Rare DiseasesNEW YORK, NY / ACCESSWIRE / June...
Netsmart Expands Predictive Analytics Solution Offerings with Acquisition of SimpleLTC
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Today, Netsmart announced it has acquired Texas-based data analytics company SimpleLTC from Briggs Healthcare. The SimpleLTC solutions...
CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60
- Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy...
AgriCann Solutions Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - AgriCann Solutions Corp. (the "Company" or "AgriCann"), a licensed full-service cannabis...
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
Qumulo Sees Unprecedented Growth in Global Healthcare Customers Managing Enterprise File Data
Leading healthcare organizations simplify and consolidate medical imaging and research datasets with the Qumulo File Data Platform SEATTLE--(BUSINESS WIRE)--Qumulo, the...
Hyperfine Names Paykel and Teisseyre to Executive Leadership Positions
Paykel to Serve as General Counsel; Teisseyre Assumes Chief Product Officer Role GUILFORD, Conn.--(BUSINESS WIRE)--#Hyperfine--Hyperfine, Inc., creators of the world’s...
Angle PLC Announces Result of AGM
ANGLE plc ('the Company') Result of 2021 Annual General MeetingGUILDFORD, SURREY / ACCESSWIRE / June 30, 2021 / ANGLE plc...
EMulate Therapeutics to Participate in Access to Giving Virtual Investor Conference July 13th – 15th, 2021
SEATTLE, WA / ACCESSWIRE / June 30, 2021 / EMulate Therapeutics Inc., a clinical-stage therapeutic device company, announced today that...
Better Plant Collaborates With Beauty Night Society With Limited Edition Asana Body & Massage Oil
VANCOUVER, BC / ACCESSWIRE / June 30, 2021 / Better Plant Sciences Inc. (CSE:PLNT)(OTCQB:VEGGF)(FSE:YG3) ("Better Plant" or the "Company") is...
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders
Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolioSAN CLEMENTE, CA...
Aptevo Therapeutics’ Scientists to Present At Virtual Cell Engager Summit
SEATTLE, WA / ACCESSWIRE / June 30, 2021 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a clinical-stage biotechnology company focused on...
Dr. Jaewon Ryu Joins Privia Health’s Board of Directors
ARLINGTON, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jaewon Ryu, MD,...
GOeVisit launches mental health assessment and support
New service helps Canadians navigate through stress, anxiety and depression concernsVANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) -- Canadian...
Novome Biotechnologies Initiates Phase 1/2a Study to Evaluate Therapeutically Engineered Bacteria for the Treatment of Enteric Hyperoxaluria
- NOV-001 is the first therapeutically engineered colonizing gut bacteria to be evaluated in humans - - Phase 1 results...
Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations
NEWPORT BEACH, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric...
Creo granted foundational patent for production of cannabinoids
Creo granted foundational patent for production of cannabinoids Patent covers advantaged method of producing essential precursor for all cannabinoids, creating...
Ethics Approval for Cynata’s Clinical Trial in Diabetic Foot Ulcers
Key highlights Ethics approval received for clinical trial in patients with diabetic foot ulcers First clinical trial to utilise the...
SELLAS Reports Promising Updated Clinical Data and Initial Immune Response Profiles from Ongoing Phase 1/2 Study of Galinpepimut-S (GPS) Combined with Keytruda for Treating WT1+ Advanced Ovarian Cancer
Updated Data Shows 100 Percent of Patients Alive and 45.5 Percent Continuing Investigational Therapy as of the Latest Follow-Up Immune...